Histological inflammation and risk of subsequent prostate cancer among men with initially elevated serum prostate‐specific antigen ( <scp>PSA</scp> ) concentration in the <scp>F</scp> innish prostate cancer screening trial

Abstract

Histological inflammation in a prostate biopsy among men with an initial false-positive screening test was not associated with an increased risk of subsequent PCa, but instead with a decreased risk which was of borderline significance. Inflammation in prostate biopsy is not a useful risk indicator in PCa screening.